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Background. Expanded HIV surveillance in TB patients forms part of the World Health Organization framework for strategic
collaborative activity. Surveillance helps understand the epidemiology of the local dual epidemic and enables design of a tailored
response to these challenges.Methods. We conducted an observational, cross-sectional study of anonymous unlinked HIV testing
for 741 consecutive TB suspects attending an urban TB facility during a seven-week period in 2008. Results. A total of 512 patients
were found to have TB. The mean age was 35.7 years, and 63% were male. The prevalence of HIV was 72.2% (95% CI: 68.2–75.9)
in all TB cases, 69.8% (95% CI: 65.3–74.2) in pulmonary tuberculosis (PTB), 81.6% (95% CI: 72.9–90.3) in extrapulmonary disease,
and 66.8% (95% CI: 60.7–72.9) in those without TB disease. HIV prevalence in TB patients was higher in females than males
and in younger age groups (18–29 years). The sex ratio of PTB patients correlated with the sex ratio of the prevalence of HIV
in the respective age groups (𝑃 < 0.05). Conclusion. The use of a rapid HIV test performed on sputum anonymously provides
an opportunity for HIV surveillance in this high-burdened setting, which has the potential to lend valuable insight into the
coepidemics.
1. Background
In South Africa, the global epicenter of both tuberculosis
(TB) and human immunodeficiency virus (HIV), the menac-
ing convergence of these diseases: one viral and one bacterial,
one emergent, and one ancient, presents a near insurmount-
able challenge to health, social, economic, and developmental
welfare [1]. These dual epidemics threaten to undo the health
care gains of the past decades in an already ailing health care
system. Women now account for nearly a half of all global
infections and 77% of all women living with HIV are in sub-
Saharan African [2]. Acquired immune deficiency syndrome
(AIDS) accounts for more deaths in women than all causes of
maternal mortality combined [2]. While the global incidence
of HIV is decreasing, new infections among young women
aged 15 to 24 years have steadily increased in South Africa,
which is due to multifactorial and complex biological, social,
economic and behavioural factors.
The World Health Organization (WHO), in an effort to
address the challenges of HIV associated TB, has proposed a
framework of strategic collaborative activities for TB andHIV
services which foster a more comprehensive approach to the
synergistic dual epidemics [3]. In settings of generalized HIV
and AIDS epidemics, like South Africa, WHO recommends
expanding HIV surveillance to include TB patients.
Anonymous unlinked testing for HIV by means of a
noninvasive sputum antibody test has been proposed as a
means of HIV surveillance within SouthAfrican TB facilities.
This approach is cost-effective, sustainable, and feasible for
rapid expansion of HIV surveillance in South Africa.
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Comprehensive HIV surveillance is central to under-
standing the epidemic, the unique challenges in each country,
the trajectory of the epidemic, resultant morbidity and
mortality, and the impact of interventions. The WHO ini-
tiated unlinked, anonymous testing (UAT) through sentinel
seroprevalence surveys amongst antenatal attendees as the
global standard for HIV surveillance where heterosexual
transmission is dominant. In UAT, blood drawn for routine
purposes in the health care setting are stripped of patients-
identifiers, unlinked from patient records, and tested for HIV
[4]. This method has the primary advantage of eliminating
nonresponse bias typically associated with other HIV surveys
where consent is required. Since then this method has
been the universally adopted standard throughout the world
and serves as the methodological basis for comparing the
prevalence of HIV across the globe, especially in generalized
epidemics.
As an additional surveillance activity to antenatal surveys,
HIV surveillance among TB patients is strongly recom-
mended, especially in countries like South Africa where TB
and HIV are deleteriously intertwined coepidemics. Expand-
ing HIV surveillance to include TB patients will serve as an
indicator of the level and maturity of the epidemic, as well as
an indicator of the effect of HIV on health services [5].
TheWHO guidelines for second generation HIV surveil-
lance reiterate the need for additional data on HIV trends,
not obtained from antenatal clinic surveys [6]. These guide-
lines promote a comprehensive HIV surveillance system, to
better understand HIV trends and the factors that drive the
epidemic in a country, by focusing on flexible surveillance in
specific high risk populations to improve prevention and care
activities [6].
The specific objectives of HIV surveillance among TB
patients in generalized HIV epidemics are (a) to inform the
targeting of resources and planning of activities for people
with HIV associated TB and for monitoring the effectiveness
of these activities; (b) to increase political, professional, and
civil society awareness of coepidemics; (c) to assess the
need for collaboration between HIV and TB programmes on
formulation and implementation of a joint TB-HIV strategy;
(d) to provide information on the HIV and AIDS epidemic
and its impact on TB patients; and (e) to quantify the need
for providing antiretroviral (ART) to TB patients [7].
One of the main challenges in conducting HIV surveil-
lance among TB patients is the ethical concerns primarily
surrounding the use of anonymous, unlinked testing. In
settings with increasing availability of ART, there is con-
siderable controversy about the ethical validity of anony-
mously testing for HIV where emphasis should be placed on
counseling and testing for HIV and the provision of ART
to patients who require it [8]. However, in general, testing
without informed consent, for the purpose of surveillance,
has been considered ethical if anonymous, unlinked testing
is employed [7]. Moreover, in generalized epidemics with a
high burden of TB-HIV coinfection, such as SouthAfrica, the
benefits of surveillance justify its inclusion as an additional
method of surveillance. HIV surveillance among TB patients
in the South African context using unlinked, anonymous
testing will increase the epidemiological utility of the data
by eliminating participation bias and will occur as part of a
response to the public health emergency characterised by TB-
HIV coinfection.
An existing challenge to anonymous, unlinked testing
for HIV among TB patients is the lack of routine blood
testing in TB on which HIV testing can piggyback. This
has fuelled concerns as to whether the inclusion of routine
bloods in TB will be driven by the covert intention to
introduce anonymous, unlinked HIV testing, rather than
out of a real need in the patient’s interest. The use of novel
methods for HIV testing on sputum specimens is rapidly
gaining momentum in response to such concerns. Sputum,
in contrast to blood, is routinely collected from TB patients,
discarded after its use, and is being shown by an expanding
evidence base to be useful in the diagnosis of HIV [7, 9–12].
The main ethical proviso regarding HIV surveillance among
TB patients is that consent may only be omitted if samples
are taken from routine specimens and testing is anonymous
and is not linked to patient identifiers. Additionally, all TB
patients included in HIV surveillance activities should have
access to Voluntary Counseling and Testing (VCT) for HIV
infection.
This paper explores anonymous unlinked HIV testing of
TB suspects as a means to understand the local coinfection
epidemic and the need to integrate services.
2. Method
2.1. Study Design. An observational, analytic, cross-sectional
study design was used.
2.2. Study Site. The survey was conducted at an out-patient
tuberculosis facility in Durban, South Africa. The clinic,
situated in the central business district adjacent to a trans-
portation nodal point, provides diagnosis and treatment
of TB for those who reside or work in Durban. Sputum
microscopy and HIV testing are conducted in the on-site
laboratory.
2.3. Study Sample. The study sample included all adult
patients presenting for TB diagnostic services who provided
a sputum specimen during the study period.
2.4. Laboratory Method. OraQuick HIV 1/2 antibody testing
was performed by a trained technician as per manufacturer
guidelines on all sputum specimens prior to discard, irrespec-
tive of its suitability for TB microscopy [13].
2.5. Statistical Analysis. All data was processed and analysed
using SAS Software (SAS 9.1.3, SAS Institute, Inc., Cary NC).
For all statistical comparisons, the 5% significance level was
used; correspondingly, 95% confidence intervals were used to
describe effect size. All data was assessed for normality, and
nonparametric tests were used where necessary. HIV preva-
lence for TB cases and suspects was calculated and selected
demographic risk factors associated with the patients HIV
status were measured using chi-squared tests for categorical
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Table 1: Age and sex characteristics of study survey cohort.
Age group Female Male Total
𝑃 value
Years 𝑛 (%) 𝑛 (%) 𝑛 (%)
<20 21 (7.7) 15 (3.2) 36 (4.9) <0.05
20–29 89 (32.5) 100 (21.4) 189 (25.5) <0.05
30–39 94 (34) 183 (39.2) 277 (37.4) 0.21
40–49 48 (17.5) 108 (23.1) 156 (21.0) 0.09
≥50 22 (8.0) 61 (13.1) 83 (11.2) <0.05
Total 274 (37.0) 467 (63.0) 741 (100)
Overall age (𝑛 = 741) mean: 35.7 years (95% CI: 34.9–36.5).
Males age (𝑛 = 467) mean: 36.9 years (95% CI: 35.9–37.9).
Females age (𝑛 = 274) mean: 33.6 years (95% CI: 32.2–35).
data (participants age categories, gender, and visit type) and
analysis of variance techniques for continuous variables (age).
2.6. Permissions. Ethical approval was obtained from the
Biomedical Research Ethics Committee of the Africa Uni-
versity of KwaZulu-Natal (Reference number BFC031/08).
Permission to conduct the study at a municipal health facility
was obtained from the eThekwini Municipality Health Unit.
3. Results
3.1. Age and Sex Characteristics of the Study Sample. The
mean age of the survey population was 35.7 years (SD ±
11.3 years). The mean ages of males and females were similar
(36.9 versus 33.6 years, 𝑃 = 0.234). Two-thirds (467/741) of
the study sample were male. Of the total, 622 (84%) were
between 20 and 50 years old, an identical proportion in both
males (84%) and females (84%) (Table 1). Only 15 (3%) of the
males were younger than 20 years old, compared to 21(8%)
of the females (𝑃 < 0.05). There was a significantly higher
proportion of males than females over 50 years of age (13%
versus 8%, 𝑃 < 0.05).
3.2. HIV Prevalence. A total of 229 (31%) TB suspects did
not have a diagnosis of TB confirmed, of which 153(66.8%,
95%CI: 60.7–72.9) tested sputumHIV antibody positive.The
balance of the study population of TB suspects, 512 (69%),
was diagnosed with TB, of which 369 (72.1%, 95% CI: 68.2–
76.0) were HIV positive. There was no statistical difference
in HIV prevalence between these two groups (𝑃 = 0.15).
The prevalence of HIV was 69.8% (95% CI: 65.3–74.2) and
81.6% (95% CI: 72.9–90.3) in those with pulmonary and
extrapulmonary TB, respectively (Figure 1).
The HIV prevalence in TB suspects accessing the clinic
varies by age, sex, and by the presence or absence of TB
disease. In those without TB disease, the age- and sex-
specific HIV prevalence reflects a similar pattern to the
general population. Females have a higher age- specific HIV
prevalence in all age groups except those 50 years and older,
have an earlier peak prevalence than males (20–29 years
versus 30–39 years), and have a higher peak prevalence

























Figure 1: HIV prevalence (95% confidence intervals) in those with
pulmonary tuberculosis (𝑛 = 407), extrapulmonary tuberculosis
(𝑛 = 105), and without tuberculosis disease (𝑛 = 229) at the clinic,
2008.
Table 2: Correlation between the change in the male-to-female sex
ratio in all PTB and HIV associated PTB and ratio of sex-specific
HIV prevalence across age groups.
Age
group
Total M : F HIV +M : F ΔM: F Male : female
(all PTB) (HIV +PTB)
(change in
ratio) HIV prevalence
<20 0.8 0.4 −0.4 0.5
20–29 1.0 0.9 −0.1 0.9
30–39 2.5 2.6 0.1 1.0
40–49 2.7 2.4 −0.3 0.9
≥50 5.3 7.5 2.2 1.4
Pearson’s correlation, one-tailed, 𝑟 = 0.87, df = 3, and 𝑃 < 0.05.
In those diagnosed with TB, the age-specific HIV preva-
lence in females was higher than inmales in age groups under
20, 20–29, and 40–49. However, the peak prevalence (86%)
of HIV in females occurred in the 40–49 years age group as
compared to a peakmaleHIV prevalence of 87% in the 30–39
years age group. Females with and without TB (overall) have
higher age- specific prevalence than males with and without
TB in the younger age groups, while the males have higher
age-specific prevalence than females in those 50 years and
older.
The male-to-female sex ratio in all patients with pul-
monary TB ranges from 0.79 in the under 20 years age group,
to 5.3 in the greater than or equal to 50 years age group
(Table 2). The representation of males increases across the
increasing age groups. In HIV associated pulmonary TB, the
male-to-female ratio ranges from 0.38 in the under 20 years
age group to 7.5 in those 50 years and older.The proportion of
females increases in the age groups less than 20 years, 20 to 29
years, and 40 to 49 years. In these age groups, the prevalence
of HIV among females is higher than the HIV prevalence
among males. There exists a significant positive correlation
(𝑟 = 0.87, 𝑃 < 0.05) between the change in the sex ratio
between all those with PTB and PTB associated HIV and the
sex ratio of HIV prevalence across the age groups.
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No TB male 0 57.1 75.6 66.7 45
No TB female 50 83.3 80.6 70 30.8
All TB male 35.7 61.5 87 72 48.8
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Figure 2: HIV prevalence by age group, sex, and TB status in the study cohort.
4. Discussion
Theprimary objective of this studywas to provide an estimate
for the prevalence of HIV among attendees at an urban TB
facility in Durban, South Africa, using a novel sputum-based
HIV antibody test. The paucity of such information in the
past has limited the ability of health services to exploit the
opportunities presented by the changing epidemiology of
TB and HIV in this setting. Analysis of the age and sex
distribution of HIV associated TB in this study reflects the
impact of a maturing HIV epidemic on TB in South Africa.
Only 37% of TB patients were female, and themale-to-female
ratio of 1.7 is lower than global and historic trends [14, 15].
Globally, in 2007, therewas a 2 : 1male-to-female ratio of cases
notified to public health authorities [16]. Nonetheless, in low
income countries, TB kills more women than all causes of
maternal mortality combined. There was more pulmonary
TB in females than in males under 30 years in this study.
This increased burden of TB in young women has been
attributed to biological, social, and methodological factors.
Young women have up to 34% higher risk of progression
to TB disease than men up to the age of 30 years initially
attributed to reduced immunity associatedwith the stresses of
pregnancy [16]. However, this hypothesis was not supported
by a case-control study which demonstrated that pregnancy
was not an exposure associated with TB disease [17]. In
addition, young women have lower cumulative TB infections
in adolescence, inferring that new postadolescence infection
might be significantly greater amongst women.New infection
with TB carries a greater likelihood to progress to TB disease,
and to do so more rapidly. Females are more likely to
encounter health services during their reproductive years,
increasing their likelihood of having TB diagnosed. Similarly,
the lower prevalence of TB disease in older women compared
to men may reflect their differential access to healthcare due
to a combination of complex social, economic, cultural, and
logistical factors. This may be particularly true in settings
such as South Africa where active case finding is too poorly
implemented to rectify possible undernotification of women
and their possible underrepresentation at health facilities.
This age-sex trend of TB is similar to WHO estimates
for other African countries with a high HIV prevalence
where there are more female than male cases notified up
to 25 years. The estimate was confirmed in this high HIV-
burdened setting, with a male-to-female ratio of 0.9 in cases
of pulmonary TB under 30 years of age.
The disproportionate burden of HIV on young women
has largely been attributed to intergenerational sex of young
women with older men, who are likely to have multiple
concurrent sexual partners [2, 18, 19]. Young women have
a 7-fold increased risk of acquiring HIV when in relation-
ships with men between 5 and 7 years older [20–23]. The
ISRN AIDS 5
exact reasons for the increased risk of acquiring HIV in
young women are not yet understood but include increased
transmissibility frommales to females, anatomy, condomuse,
sexual networking, poverty, education, economic autonomy,
power imbalances between men and women, gender based
violence, access to sexual and reproductive health services,
and political and sociocultural issues [2]. The pattern of a
higher HIV prevalence among young women in comparison
to men in the same age group is now being reflected in
the age-specific trends of TB. The impact of HIV on TB is
reflected in the age-specific HIV prevalence figures generated
by this study and confirms that HIV is shaping the evolving
epidemiology of TB in this setting.
With nearly 70% of all TB patients being coinfected with
HIV, it is not surprising that the age and sex distribution
of TB is increasingly resembling the distribution of HIV
in this region of hyperendemicity. The male-to-female ratio
among HIV negative individuals was 1.98 while the male-to-
female ratio among those living with HIV drops to 1.58. The
increased representation of females in comparison tomales in
HIV associated pulmonary TB is significantly correlated with
the sex-specific HIV prevalence figures in those age groups.
There is a clear indication that HIV is driving the increased
representation of females among TB patients with age groups
in which females have the higher HIV prevalence containing
a greater number of females with TB. A previous study in this
setting demonstrated a significantly higher burden of TB dis-
ease amongwomen in the 20 to 29 years age group, in keeping
with predictions by mathematical models on the impact of
HIV on TB in areas of dual hyperendemicity [24]. Whether
this is due to biological or structural reasons is uncertain,
but the greater representation of females at TB facilities in
high HIV settings has multiple programmatic implications.
A growing recognition of the gradually changing face of
TB in this setting will allow for the exploitation of the
opportunities presented by this evolving epidemiology. The
unique opportunity to seek out synergies between TB-HIV
and women’s health services must be seized. The broadening
of services may serve to appropriately orientate the existing
TB services with regards to the changing demographic profile
of patients to augment women’s health services, to respond to
the need for comprehensive primary health care services, and,
most importantly, to acknowledge the presence of multiple
pathologies in an individual patient that cannot adequately
be addressed by a vertical programme design.
5. Conclusions
The demographic profile of TB patients mirrors the patterns
observed in those living with HIV and suggests that HIV
infection does fuel the TB epidemic in this setting. The
increased number of young women, in particular, at TB
services presents the opportunity to design more demo-
graphically sensitive TB services which include a more com-
prehensive health service package. The benefit of including
women friendly reproductive health services at TB facilities
requires further evaluation.Overall, this survey demonstrates
the possibility of using a novel HIV antibody assay on
sputum and an anonymous survey design for achieving
additional HIV surveillance in a generalized HIV epidemic
with TB endemicity. A better understanding of both of
these epidemics and how they interact is crucial to optimise
a consolidated comprehensive public health response. The
richness of data that is generated is a clear indication of the
potential benefits that may accrue from better understanding
the confluence of these dual epidemics. The idea of an
expanded surveillance programme for HIV in TB facilities
is a direct response to a call from WHO to optimize the
position of health systems to understand, appreciate, and
react to the emerging destructive synergy between TB and
HIV epidemics.
This study has highlighted that the problem of TB-
HIV coinfection is not a homogenous entity but rather a
composite of many complex subepidemics. This is largely
due to the various drivers of HIV and TB which have
differential effects on various strata of the population, most
notably subpopulations by age and sex. A striking feature
of the TB-HIV coepidemic is the direct influence that the
epidemiology of HIV has had on the evolving TB epidemic,
with young women representing a significant proportion of
TB facility attendees.Themajority of TB patients are now also
in the economically active age group. The hyperendemicity
of TB and HIV in South Africa coupled with the existing
demographic distribution of the coepidemics has serious
implications for the social, health, and economic status of the
nation and threatens to be a significant limitation to national
growth and development. Vertical programme designs have
failed to demonstrate that they are capable of responding to
the synergism of multiple morbidities in individuals. A more
integrated approach is more attractive as it promises the pos-
sibility of increasing clinical and operational efficiency. This
is the central theme of the WHO call for closer collaboration
between TB and HIV services. However, the guiding tenet
of all health care initiatives is to ensure that programmes are
responsive to the needs of patients and that any intervention
is tailored to respond to those needs while being informed
by the unique epidemiology of the local epidemic. The local
epidemic, as demonstrated in this study, is characterised
by a broad cross-section of patients, with the majority of
coinfected individuals in the economically active age group,
and with the majority of women in their reproductive years.
There are therefore several opportunities to maximize the
impact of any healthcare contact with these individuals when
they present to a TB facility. Sexual health services, in
particular, would be well positioned in TB facilities and could
aim to provide sexual health education, positive prevention,
condom promotion, screening for sexually transmitted dis-
eases, and the treatment thereof.
This study has confirmed that the burden young women
face in terms of their heightened vulnerability for HIV
infection has been translated to an increased vulnerability for
TB. Existing TB programmes do not adequately reflect the
needs of young women in their design. Women’s health and
basic reproductive health services would have a significant
target audience at TB facilities. This might include access
to family planning, Pap smear evaluations, and targeted
interventions for young women such as microbicide gels in
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future. A more comprehensive service may lead to greater
public access, more equitable access for all patients, a more
convenient and satisfying service, and better health overall.
New TB service design must begin to reflect the presence of
young women as a significant group burdened by the disease.
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